Terms: = Gastric cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Prognosis
266 results:
1. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the pi3k/Akt pathway.
Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X
BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039
[TBL] [Abstract] [Full Text] [Related]
2. KIF3C: an emerging biomarker with prognostic and immune implications across pan-cancer types and its experiment validation in gastric cancer.
Zhong Q; Hong W; Xiong L
Aging (Albany NY); 2024 Mar; 16(7):6163-6187. PubMed ID: 38552217
[TBL] [Abstract] [Full Text] [Related]
3. PXMP4 promotes gastric cancer cell epithelial-mesenchymal transition via the pi3k/AKT signaling pathway.
Li W; Dong X; Wan Z; Wang W; Zhang J; Mi Y; Li R; Xu Z; Wang B; Li N; He G
Mol Biol Rep; 2024 Feb; 51(1):350. PubMed ID: 38401002
[TBL] [Abstract] [Full Text] [Related]
4. TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate pi3k-Akt-mTOR pathway and is a therapeutic target.
Shi L; Wang X; Guo S; Gou H; Shang H; Jiang X; Wei C; Wang J; Li C; Wang L; Zhao Z; Yu W; Yu J
Oncogene; 2024 Mar; 43(13):931-943. PubMed ID: 38341472
[TBL] [Abstract] [Full Text] [Related]
5. [High expression of CPNE3 correlates with poor long-term prognosis of gastric cancer by inhibiting cell apoptosis
Duan T; Zhang Z; Shi J; Xiao L; Yang J; Yin L; Zhang X; Geng Z; Lu G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):129-137. PubMed ID: 38293984
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract] [Full Text] [Related]
7. MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/pi3k/AKT signaling pathway activation.
Yu S; Chen C; Chen M; Liang J; Jiang K; Lou B; Lu J; Zhu X; Zhou D
J Exp Clin Cancer Res; 2024 Jan; 43(1):32. PubMed ID: 38268030
[TBL] [Abstract] [Full Text] [Related]
8. Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models.
Puliga E; De Bellis C; Vietti Michelina S; Capeloa T; Migliore C; Orrù C; Baiocchi GL; De Manzoni G; Pietrantonio F; Reddavid R; Fumagalli Romario U; Ambrogio C; Corso S; Giordano S
Gastric Cancer; 2024 May; 27(3):473-483. PubMed ID: 38261067
[TBL] [Abstract] [Full Text] [Related]
9. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
10. The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5-fluorouracil resistance by targeting the pi3k/AKT/mTOR signaling pathway.
Han A; Liu T; Du P; Wang M; Liu J; Chen L
Mol Carcinog; 2024 Apr; 63(4):688-700. PubMed ID: 38224261
[TBL] [Abstract] [Full Text] [Related]
11. Dual pi3k/mTOR inhibitor PF-04979064 regulates tumor growth in gastric cancer and enhances drug sensitivity of gastric cancer cells to 5-FU.
Zhong Z; Wang T; Zang R; Zang Y; Feng Y; Yan S; Geng C; Zhu N; Wang Q
Biomed Pharmacother; 2024 Jan; 170():116086. PubMed ID: 38159377
[TBL] [Abstract] [Full Text] [Related]
12. The role of α7-nAChR-mediated pi3k/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
13. The genomic and immune landscapes of gastric cancer and their correlations with HER2 amplification and PD-L1 expression.
Jing X; Luo Z; Wu J; Ye F; Li J; Song Z; Zhang Y; Shi M; Sun H; Fang Y; Jiang Y; Ji X
Cancer Med; 2023 Dec; 12(24):21905-21919. PubMed ID: 38050871
[TBL] [Abstract] [Full Text] [Related]
14. Cross-talk between gastric cancer and hepatic stellate cells promotes invadopodia formation during liver metastasis.
Ren C; Yang Z; Xu E; Kang X; Wang X; Sun Q; Wang C; Zhang L; Miao J; Luo B; Chen K; Liu S; Shen X; Lu X; Yin K; Wang M; Xia X; Guan W
Cancer Sci; 2024 Feb; 115(2):369-384. PubMed ID: 38050654
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive analysis of the function of helicobacter-associated ferroptosis gene YWHAE in gastric cancer through multi-omics integration, molecular docking, and machine learning.
Liu D; Peng J; Xie J; Xie Y
Apoptosis; 2024 Apr; 29(3-4):439-456. PubMed ID: 38001345
[TBL] [Abstract] [Full Text] [Related]
16. Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the pi3k/AKT/mTOR pathway in gastric cancer.
Jin Y; Xia Y; Du H; Xiang T; Lan B; Wei S; Li H; Huang H
Biochem Biophys Res Commun; 2023 Dec; 689():149188. PubMed ID: 37976838
[TBL] [Abstract] [Full Text] [Related]
17. [High expression of RAB7A is associated with poor prognosis of gastric cancer by promoting tumor invasion].
Zhang M; Liu S; Zhang N; Zhang W; Xia Y; Song X; Zhang X; Zuo L; Li J; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1734-1743. PubMed ID: 37933649
[TBL] [Abstract] [Full Text] [Related]
18. Identification and validation of key genes associated with pathogenesis and prognosis of gastric cancer.
Li A; Li Y; Li Y; Zhang M; Zhang H; Chen F
PeerJ; 2023; 11():e16243. PubMed ID: 37868053
[TBL] [Abstract] [Full Text] [Related]
19. AXL - a new player in resistance to HER2 blockade.
Adam-Artigues A; Arenas EJ; Arribas J; Prat A; Cejalvo JM
Cancer Treat Rev; 2023 Dec; 121():102639. PubMed ID: 37864955
[TBL] [Abstract] [Full Text] [Related]
20. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in gastric cancer.
Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y
Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125
[TBL] [Abstract] [Full Text] [Related]
[Next]
